Atrium Therapeutics, Inc. (RNA)
10.36
-0.15
(-1.43%)
USD |
NASDAQ |
Sep 10, 16:00
10.36
0.00 (0.00%)
After-Hours: 18:09
Atrium Therapeutics Total Liabilities (Quarterly) : 65.94M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 65.94M |
| March 31, 2026 | 58.26M |
| December 31, 2025 | 71.66M |
| Date | Value |
|---|---|
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | 69.84M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | 8.073M |
| Exicure, Inc. | 10.42M |
| Century Therapeutics, Inc. | 54.66M |
| Absci Corp. | 22.79M |
| Celularity, Inc. | 340.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 280.51M |
| Shareholders Equity (Quarterly) | 214.58M |
| Debt to Equity Ratio | 0.0078 |
| Current Ratio | 8.730 |
| Net Debt Paydown Yield | 0.44% |